Literature DB >> 24463674

Prevalence and trends of symptomatic pelvic floor disorders in U.S. women.

Jennifer M Wu1, Camille P Vaughan, Patricia S Goode, David T Redden, Kathryn L Burgio, Holly E Richter, Alayne D Markland.   

Abstract

OBJECTIVE: To estimate the prevalence and trends of these pelvic floor disorders in U.S. women from 2005 to 2010.
METHODS: We used the National Health and Nutritional Examination Survey from 2005-2006, 2007-2008, and 2009-2010. A total of 7,924 nonpregnant women (aged 20 years or older) were categorized as having: urinary incontinence (UI)-moderate to severe (3 or higher on a validated UI severity index, range 0-12); fecal incontinence-at least monthly (solid, liquid, or mucus stool); and pelvic organ prolapse-seeing or feeling a bulge. Potential risk factors included age, race and ethnicity, parity, education, poverty income ratio, body mass index ([BMI] less than 25, 25-29, 30 or greater), comorbidity count, and reproductive factors. Using appropriate sampling weights, weighted χ analysis and multivariable logistic regression models with odds ratios and 95% confidence intervals (95% CIs) were reported.
RESULTS: The weighted prevalence rate of one or more pelvic floor disorders was 25.0% (95% CI 23.6-26.3), including 17.1% (95% CI 15.8-18.4) of women with moderate-to-severe UI, 9.4% (95% CI 8.6-10.2) with fecal incontinence, and 2.9% (95% CI 2.5-3.4) with prolapse. From 2005 to 2010, no significant differences were found in the prevalence rates of any individual disorder or for all disorders combined (P>.05). After adjusting for potential confounders, higher BMI, greater parity, and hysterectomy were associated with higher odds of one or more pelvic floor disorders.
CONCLUSION: Although rates of pelvic floor disorders did not change from 2005 to 2010, these conditions remain common, with one fourth of adult U.S. women reporting at least one disorder. LEVEL OF EVIDENCE: III.

Entities:  

Mesh:

Year:  2014        PMID: 24463674      PMCID: PMC3970401          DOI: 10.1097/AOG.0000000000000057

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  157 in total

1.  The association between different measures of pelvic floor muscle function and female pelvic organ prolapse.

Authors:  Sissel H Oversand; Ixora Kamisan Atan; Ka Lai Shek; Hans Peter Dietz
Journal:  Int Urogynecol J       Date:  2015-08-07       Impact factor: 2.894

2.  Prevalence and degree of bother of pelvic floor disorder symptoms among women from primary care and specialty clinics in Lebanon: an exploratory study.

Authors:  Lilian Ghandour; Vatche Minassian; Ahmed Al-Badr; Rami Abou Ghaida; Sandra Geagea; Tony Bazi
Journal:  Int Urogynecol J       Date:  2016-07-09       Impact factor: 2.894

3.  Clinical application of IUGA/ICS classification system for mesh erosion.

Authors:  Rebecca Posthuma Batalden; Milena M Weinstein; Caroline Foust-Wright; Marianna Alperin; May M Wakamatsu; Samantha J Pulliam
Journal:  Neurourol Urodyn       Date:  2015-04-14       Impact factor: 2.696

4.  The effect of hydroxyquinoline-based gel on pessary-associated bacterial vaginosis: a multicenter randomized controlled trial.

Authors:  Kate V Meriwether; Rebecca G Rogers; Ellen Craig; Sean D Peterson; Robert E Gutman; Cheryl B Iglesia
Journal:  Am J Obstet Gynecol       Date:  2015-04-30       Impact factor: 8.661

5.  Obesity and stress urinary incontinence in women: compromised continence mechanism or excess bladder pressure during cough?

Authors:  Carolyn W Swenson; Giselle E Kolenic; Elisa R Trowbridge; Mitchell B Berger; Christina Lewicky-Gaupp; Rebecca U Margulies; Daniel M Morgan; Dee E Fenner; John O DeLancey
Journal:  Int Urogynecol J       Date:  2017-02-01       Impact factor: 2.894

6.  The role of tenascin-X in the uterosacral ligaments of postmenopausal women with pelvic organ prolapse: an immunohistochemical study.

Authors:  Barbara Bodner-Adler; Klaus Bodner; Oliver Kimberger; Ksenia Halpern; Cora Schneidinger; Peter Haslinger; Christian Schneeberger; Reinhard Horvat; Wolfgang Umek
Journal:  Int Urogynecol J       Date:  2018-12-10       Impact factor: 2.894

7.  Efficacy and safety of skeletonized mesh implants for advanced pelvic organ prolapse: 12-month follow-up.

Authors:  Adi Y Weintraub; Menahem Neuman; Yonatan Reuven; Joerg Neymeyer; Naama Marcus-Braun
Journal:  World J Urol       Date:  2016-02-23       Impact factor: 4.226

8.  Pelvic Floor Symptoms and Spinal Curvature in Women.

Authors:  Isuzu Meyer; Tatum A McArthur; Ying Tang; Jessica L McKinney; Sarah L Morgan; Holly E Richter
Journal:  Female Pelvic Med Reconstr Surg       Date:  2016 Jul-Aug       Impact factor: 2.091

9.  Perioperative complications following colpocleisis with and without concomitant vaginal hysterectomy.

Authors:  Katarzyna Bochenska; Alix Leader-Cramer; Margaret Mueller; Bhumy Davé; Alexandria Alverdy; Kimberly Kenton
Journal:  Int Urogynecol J       Date:  2017-05-03       Impact factor: 2.894

10.  Comparing different tissue-engineered repair materials for the treatment of pelvic organ prolapse and urinary incontinence: which material is better?

Authors:  Xiaojuan Wang; Yisong Chen; Zhongyong Fan; Keqin Hua
Journal:  Int Urogynecol J       Date:  2017-07-20       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.